Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer

James P. Buteau, Daniel Moon, Michael T. Fahey, Matthew J. Roberts, James Thompson, Declan G. Murphy, Nathan Papa, Catherine Mitchell, Richard De Abreu Lourenco, Haryana M. Dhillon, Veeru Kasivisvanathan, Roslyn J. Francis, Phillip Stricker, Shihka Agrawal, Jonathan O'Brien, Aoife McVey, Gaurav Sharma, Sidney Levy, Narjess Ayati, Andrew NguyenSu Faye Lee, David A. Pattison, Dinesh Sivaratnam, Mark Frydenberg, Yang Du, Jehan Titus, Sze Ting Lee, Joseph Ischia, Greg Jack, Michael S. Hofman, Louise Emmett

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer'. Together they form a unique fingerprint.

Medicine and Dentistry